Regeneron Pharmaceuticals (REGN)
NASDAQHealth CareBiotechnologySnapshot 2026-07-08
$662.88-1.97%
Close 2026-07-08 · 1-day change
Reading REGN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track REGN free→NASDAQHealth CareBiotechnologySnapshot 2026-07-08
Reading REGN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track REGN free→QuarterlyIQ Insights · REGN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 14,919.6 | 14,342.9 | 14,202.0 | 13,117.2 | 12,172.9 | 16,071.7 | 8,497.1 | 7,863.4 | 4,860.4 | 4,860.4 | 4,860.4 | 4,103.7 | 1,378.5 | 1,378.5 | 1,378.5 | 445.8 | 238.5 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 4,860.4 | 4,860.4 | 4,103.7 | 1,378.5 | 1,378.5 | 1,378.5 | 445.8 | 238.5 |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 2,714.7 | 2,700.0 | 2,954.4 | 2,631.3 | 2,115.9 | 1,824.9 | 1,346.0 | 1,834.8 | 1,177.7 | 1,177.7 | 1,177.7 | 838.5 | 210.8 | 210.8 | 210.8 | 117.3 | 48.9 |
| R&D Expenses | 6,066.3 | 5,850.2 | 5,132.0 | 4,439.0 | 3,592.5 | 2,860.1 | 2,647.0 | 3,036.6 | 2,052.3 | 2,052.3 | 2,052.3 | 1,620.6 | 625.6 | 625.6 | 625.6 | 529.5 | 274.9 |
| Other Operating Expenses, Total | — | 10.0 | (53.4) | 2.1 | 89.9 | 45.6 | 280.4 | — | — | — | — | — | — | — | — | — | — |
| Operating Income | 3,629.1 | 3,577.9 | 3,990.7 | 4,047.1 | 4,738.9 | 8,946.8 | 3,576.6 | 2,209.8 | 1,330.7 | 1,330.7 | 1,330.7 | 1,251.9 | 457.7 | 457.7 | 457.7 | (205.2) | (86.2) |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | — | — | 73.0 | 59.4 | 57.3 | 56.9 | 30.2 | 7.2 | — | — | 14.2 | 45.3 | 45.3 | 45.3 | 21.3 | 7.8 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.0 | 2.0 | 3.5 | 18.2 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | 43.3 | 43.3 | 17.7 | (10.4) |
| Other Non-Operating Income / Expenses | 1,527.8 | 1,652.8 | 789.2 | 152.2 | 119.9 | 379.0 | 233.8 | 219.3 | (0.9) | (0.9) | (0.9) | (26.8) | (43.3) | (43.3) | (43.3) | (17.7) | 9.5 |
| EBT, Incl. Unusual Items | 5,156.9 | 5,230.7 | 4,779.9 | 4,199.3 | 4,858.8 | 9,325.8 | 3,810.4 | 2,429.1 | 1,329.8 | 1,329.8 | 1,329.8 | 1,225.1 | 414.4 | 414.4 | 414.4 | (222.9) | (76.8) |
| Income Tax Expense | 733.5 | 725.8 | 367.3 | 245.7 | 520.4 | 1,250.5 | 297.2 | 313.3 | 434.3 | 434.3 | 434.3 | 589.0 | (335.8) | (335.8) | (335.8) | (1.1) | 2.4 |
| Net Income | |||||||||||||||||
| Net Income | 4,423.4 | 4,504.9 | 4,412.6 | 3,953.6 | 4,338.4 | 8,075.3 | 3,513.2 | 2,115.8 | 895.5 | 895.5 | 895.5 | 636.1 | 750.3 | 750.3 | 750.3 | (221.8) | (79.1) |
| Per Share | |||||||||||||||||
| Basic EPS | 42.53 | 43.07 | 40.90 | 37.05 | 40.51 | 76.40 | 32.65 | 19.38 | 8.55 | 8.55 | 8.55 | 6.17 | 7.92 | 7.92 | 7.92 | — | — |
| Diluted EPS | 41.07 | 41.48 | 38.34 | 34.77 | 38.22 | 71.97 | 30.52 | 18.46 | 7.70 | 7.70 | 7.70 | 5.52 | 6.75 | 6.75 | 6.75 | — | — |
| Revenue per Share | 138.53 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | 3.58 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 104.0 | 104.6 | 107.9 | 106.7 | 107.1 | 105.7 | 107.6 | 109.2 | 104.7 | 104.7 | 104.7 | 103.1 | 94.7 | 94.7 | 94.7 | — | — |
| Diluted Weighted Avg Shares | 107.7 | 108.6 | 115.1 | 113.7 | 113.5 | 112.2 | 115.1 | 114.6 | 116.3 | 116.4 | 116.4 | 115.2 | 115.4 | 115.4 | 115.4 | — | — |
| Payout Ratio | 8.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | |||||||||||||||||
| EBITDA | — | 4,121.6 | 4,473.6 | 4,468.1 | 5,080.3 | 9,233.0 | 3,812.5 | 2,420.1 | 1,435.4 | 1,435.5 | 1,435.5 | 1,326.8 | 494.7 | 494.7 | 494.7 | (174.1) | (75.0) |
| EBIT | 3,629.1 | 3,577.9 | 3,990.7 | 4,047.1 | 4,738.9 | 8,946.8 | 3,576.6 | 2,209.8 | 1,330.7 | 1,330.7 | 1,330.7 | 1,251.9 | 457.7 | 457.7 | 457.7 | (205.2) | (86.2) |
| Effective Tax Rate | 14.2% | 13.9% | 7.7% | 5.9% | 10.7% | 13.4% | 7.8% | 12.9% | 32.7% | 32.7% | 32.7% | 48.1% | -81.0% | -81.0% | -81.0% | 0.5% | -3.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.